green
Positive treatment
10.8 score
Treatment trajectory · 1990 → 2026 · click a year to view as-of
1990
2008
2026
Top citers, strongest first. 33 distinct citers.
How cited ↗
discussed
Cited "see"
Arabie v. Citgo Petroleum Corp.
(2×)
See Brock v. Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307 (5th Cir.1989), modified by 884 F.2d 166 (5th Cir.1989), cert. denied, 494 U.S. 1046 , 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990) (lack of conclusive epidemiological proof was fatal to plaintiffs’ case); and see Allen v. Pennsylvania Engineering Corp., 102 F.Sd 194 (5 Cir.1996) (most useful and conclusive evidence is epidemiological studies; numerous reputable epidemiological studies indicate there is not a correlation between ethylene oxide exposure and cancer of the human brain).
discussed
Cited "see"
State of Tennessee v. Paul Dennis Reid, Jr.
See generally State v. Pilkey, 776 S.W.2d 943, 945 (Tenn. 1989), cert. denied, 494 U.S. 1046 , 110 S. Ct. 1510 (1990) (trial occurred after effective date of statute authorizing use of ex parte videotaped statement of child victim, thus, no ex post facto claim).
discussed
Cited "see"
Russell Corp. v. Sullivan
(2×)
See Brock v. Merrell Dow Pharmaceuticals, Inc., 874 F.2d 307, 312-13 (5th Cir.1989), cert. denied 494 U.S. 1046 , 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990)." 989 F.2d at 828 . [4] In Prescott v. Leaf River Forest Products, Inc., 740 So.2d 301 (Miss.1999), a case involving analogous facts, the Mississippi Supreme Court upheld a summary judgment in favor of Leaf River Forest Products, Inc., "against property owners along the Leaf River claiming damage[] resulting from chemical wastes deposited into the Leaf River during the operations of a pulp mill." 740 So.2d at 304-05 .
discussed
Cited "see"
ARA Automotive Group v. Central Garage, Inc.
(2×)
See Brock v. Merrell Dow Pharmaceuticals, Inc., 874 F.2d 307, 308 (5th Cir.1989), cert. denied, 494 U.S. 1046 , 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990).
discussed
Cited "see"
Cuevas v. EI DuPont De Nemours and Co.
(2×)
See Brock v. Merrell Dow Pharmaceuticals, Inc., 874 F.2d 307 (5th Cir.1989), cert. denied, 494 U.S. 1046 , 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990) (ruling that “courts must be skeptical of medical and other scientific evidence that has not been subjected to thorough peer review.”) With these facts, the third element of potential error and the fourth element of general acceptance are not met by Dr. Parent’s opinion.
examined
Cited "see"
Crest Ridge Construction Group, Inc. v. Newcourt Inc.
(4×)
See Brock v. Merrell Dow Pharmaceuticals, Inc., 874 F.2d 307, 308-09 (5th Cir.), modified, by 884 F.2d 166 (5th Cir.1989), cert. denied, 494 U.S. 1046 , 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990). 2 The Uniform Commercial Code governs the substantive legal issues in this case.
examined
Cited "see"
Maritime Overseas Corp. v. Ellis
(4×)
See Brock v. Merrell Dow Pharmaceuticals, Inc., 874 F.2d 307, 309 (5th Cir.), modified on reh’g, 884 F.2d 167 (5th Cir.1989), cert. denied, 494 U.S. 1046 , 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990) (hereinafter referred to as Brock I and Brock II).
discussed
Cited "see"
Rickey Bernard Roberts v. Harry K. Singletary, Secretary, Florida Department of Corrections
(2×)
See Smith v. Dugger, 840 F.2d 787, 796 (11th Cir.1988), cert. denied, 494 U.S. 1047 , 110 S.Ct. 1511 , 108 L.Ed.2d 647 (1990).
discussed
Cited "see"
Sorensen ex rel. Dunbar v. Shaklee Corp.
(2×)
See Brock v. Merrell Dow Pharmaceuticals, Inc., 874 F.2d 307 , modified on reh'g, 884 F.2d 166 (5th Cir.1989), cert. denied, 494 U.S. 1046 , 110 S.Ct 1511 , 108 L.Ed.2d 646 (1990); Richardson v. Richardson-Merrell, Inc., 857 F.2d 823 (D.C.Cir.1988), cert. denied, 493 U.S. 882 , 110 S.Ct. 218 , 107 L.Ed.2d 171 (1989); Lynch v. Merrell-National Lab., Div. of Richardson-Merrell, Inc., 830 F.2d 1190 (1st Cir.1987). .
discussed
Cited "see"
James Berry, Sr., James Berry, Sr. v. The Armstrong Rubber Company, J. Wesley Cooper v. The Armstrong Rubber Company
(2×)
See Brock v. Merrell Dow Pharmaceutical, Inc., 874 F.2d 307, 312-13 (5th Cir.1989), cert. denied 494 U.S. 1046 , 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990). 6.
discussed
Cited "see"
Devine v. Rhode Island
(2×)
See Morales-Feliciano v. Patole Board of Puerto Rico, 887 F.2d 1, 4-5 (1st Cir.1989), cert. denied, 494 U.S. 1046 , 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990).
discussed
Cited "see"
Berry v. Armstrong Rubber Co.
(2×)
See Brock v. Merrell Dow Pharmaceutical, Inc., 874 F.2d 307, 312-13 (5th Cir.1989), cert. denied 494 U.S. 1046 , 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990). 6.
cited
Cited "see"
Project B.A.S.I.C. v. Jack Kemp, Secretary of Housing and Urban Development, Phoenix-Griffin Group Ii, Ltd. v. Jack Kemp, Secretary of Housing and Urban Development, Jack Kemp, Secretary of Housing and Urban Development, and United States Department of Housing and Urban Development
See Morales-Feliciano v. Parole Board, 887 F.2d 1, 3 (1st Cir.1989), cert. denied, --- U.S. ----, 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990).
cited
Cited "see"
Project B.A.S.I.C. v. Kemp
See Morales-Feliciano v. Parole Board, 887 F.2d 1, 3 (1st Cir.1989), cert. denied, — U.S. —, 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990).
discussed
Cited "see"
Christophersen v. Allied-Signal Corporation
See Brock v. Merrell Dow Pharmaceuticals, 874 F.2d 307 (5th Cir.1989), cert. denied, --- U.S. ----, 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990) Moreover, even though the Osburn criteria are met, the opinion may nevertheless be excludable under Rule 403. 9 One commentator has sought to capture the distinction between an expert's methodology (or reasoning) and an expert's conclusion by evaluating the former according to its scientific "validity" and the latter according to its legal "reliability." Bert Black, A Unified Theory of Scientific Evidence, 56 Fordham L.Rev. 595 (1988).
cited
Cited "see"
Christophersen v. Allied-Signal Corp.
See Brock v. Merrett Dow Pharmaceuticals, 874 F.2d 307 (5th Cir.1989), cert. denied, — U.S. —, 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990).
discussed
Cited "see"
Rubanick v. Witco Chemical Corp.
See Brock v. Merrell Dow Pharmaceutical, Inc., 874 F.2d 307, 310 (in finding plaintiffs’ expert testimony that Bendectin caused child’s birth defects inadmissible, court praised Agent Orange and criticized Ferebee for not' being “willing to analyze the reasoning employed by experts to reach their conclusions”), modified on other grounds, 884 F.2d 166 (5th Cir.1989), cert. denied, — U.S.-, 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990); Sterling v. Velsicol Chem.
cited
Cited "see"
Project B.A.S.I.C. v. Kemp
See Morales-Feliciano v. Parole Board of Puerto Rico, 887 F.2d 1, 4-6 (1st Cir.1989), cert. denied, — U.S.-, 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990).
cited
Cited "see"
Mercer v. Mitchell
See Morales-Feliciano v. Parole Board, 887 F.2d 1, 6-7 (1st Cir.1989), cert. denied, --- U.S. ----, 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990).
cited
Cited "see"
Mercer v. Mitchell
See Morales-Feliciano v. Parole Board, 887 F.2d 1, 6-7 (1st Cir.1989), cert. denied, — U.S. -, 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990).
cited
Cited "see"
Christophersen v. Allied-Signal Corporation
See Brock v. Merrell Dow Pharmaceuticals, Inc., 874 F.2d 307 (5th Cir.), modified, 884 F.2d 166 (5th Cir.1989), cert. denied, --- U.S. ----, 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990).
cited
Cited "see"
Christophersen v. Allied-Signal Corp.
See Brock v. Merrell Dow Pharmaceuticals, Inc., 874 F.2d 307 (5th Cir.), modified, 884 F.2d 166 (5th Cir.1989), ce rt. denied, — U.S. -, 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990).
discussed
Cited "see"
James BERRY, Sr., et al., Plaintiffs, James Berry, Sr., et al v. The ARMSTRONG RUBBER COMPANY
(2×)
See Brock v. Merrell Dow Pharmaceutical, Inc., 874 F.2d 307, 312-13 (5th Cir.1989), cert. denied 494 U.S. 1046 , 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990). 6.
discussed
Cited "see, e.g."
Dobbs v. Turpin
(2×)
See, e.g., Smith v. Dugger, 840 F.2d 787, 795 (11th Cir.1988) (finding that lawyer who, after an exhaustive background search, decided not to present mitigating evidence at a sentencing hearing based on a strategic decision was not ineffective), cert. denied, 494 U.S. 1047 , 110 S.Ct. 1511 , 108 L.Ed.2d 647 (1990).
discussed
Cited "see, e.g."
Dobbs v. Turpin
(2×)
See, e.g., Smith v. Dugger, 840 F.2d 787, 795 (11th Cir.1988) (finding that lawyer who, after an exhaustive background search, decided not to present mitigating evidence at a sentencing hearing based on a strategic decision was not ineffective), cert. denied, 494 U.S. 1047 , 110 S.Ct. 1511 , 108 L.Ed.2d 647 (1990).
discussed
Cited "see, e.g."
In Re Dow Corning Corp.
(2×)
See also Brock v. Merrell Dow Pharm., Inc., 874 F.2d 307, 315 (5th Cir.) (holding that lack of epidemiology supporting plaintiffs’ causation theory was fatal to their ease notwithstanding possibility “that new and conclusive studies [may] emerge which would give a jury a firmer basis on which to determine the issue of causation”), modified on other grounds, 884 F.2d 166 (5th Cir.1989) (per curiam), cert. denied, 494 U.S. 1046 , 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990); Turpin v. Merrell Dow Pharm., Inc., 736 F.Supp. 737, 744 (E.D.Ky.1990) (“until new and conclusive medical and epidemiol…
discussed
Cited "see, e.g."
United States v. Douglas Nyhuis, United States of America v. Anicia Marivel Ripoll, A/K/A Anicia Goodman
(2×)
See, e.g., Smith v. Dugger, 840 F.2d 787, 791 (11th Cir.1988) (declining to decide a procedural default issue because after considering “the merits it [was] apparent there [was] no substance to the constitutional claim”), cert. denied, 494 U.S. 1047 , 110 S.Ct. 1511 , 108 L.Ed.2d 647 (1990).
discussed
Cited "see, e.g."
Keene Corp. v. Hall
(2×)
See, e.g., Brock v. Merrell Dow Pharmaceutical, Inc., 874 F.2d 307, 313-15 , modified, 884 F.2d 166 (5th Cir.1989), cert. denied, 494 U.S. 1046 , 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990); Lynch v. Merrell-National Laboratories, 830 F.2d 1190, 1195 (1st Cir.1987).
discussed
Cited "see, e.g."
Charlotte Kennedy Robert L. Kennedy v. Collagen Corporation
See also Brock v. Merrell Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-13 (5th Cir.1989), cert. denied, 494 U.S. 1046 (1990); DeLuca, 911 F.2d at 949-52 (discussing Bendectin case law from other circuits).
discussed
Cited "see, e.g."
prod.liab.rep. (Cch) P 13,013 Mary Kathryn Thomas v. Hoffman-Laroche, Inc.
See, e.g., Brock v. Merrell Dow Pharmaceuticals, Inc., 874 F.2d 307, 308-09 (5th Cir.), modified on other grounds on rehearing, 884 F.2d 166 (5th Cir.1989), cert. denied, — U.S. -, 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990). 36 .
discussed
Cited "see, e.g."
Commonwealth v. Lavalley
See also State v. Pilkey, 776 S.W.2d 943, 951 (Tenn. 1989), cert, denied, 494 U.S. 1032 and 494 U.S. 1046 (1990) (admission for substantive purposes of videotape statement of sexual assault victim violated defendant’s confrontation rights). 6 During the trial, the Commonwealth did not contend that the statement made by the victim and recorded in the videotape was a spontaneous utterance, see Commonwealth v. McLaughlin, 364 Mass. 211, 223 (1973), and therefore it did not attempt to introduce the videotape as substantive evidence that the defendant raped the victim.
cited
Cited "see, e.g."
In Re Paoli Railroad Yard Pcb Litigation
See also Brock v. Merrell Dow Pharmaceuticals, Inc., 874 F.2d 307, 313 , modified per curiam 884 F.2d 166 (5th Cir.1989), cert. denied, --- U.S. ----, 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990).
cited
Cited "see, e.g."
Brown v. Monsanto Co.
See also Brock v. Merrell Dow Pharmaceuticals, Inc., 874 F.2d 307, 313, modified per curiam 884 F.2d 166 (5th Cir.1989), cert. denied, — U.S. -, 110 S.Ct. 1511 , 108 L.Ed.2d 646 (1990).
Retrieving the full opinion text from the archive…
Egly
v.
Minnesota Mining & Manufacturing Co.
v.
Minnesota Mining & Manufacturing Co.
No. 89-1318.
Supreme Court of the United States.
Mar 19, 1990.
Cited by 14 opinions | Published
C. A. Fed. Cir. Certiorari denied. Justice BlacKmun took no part in the consideration or decision of this petition.